157 related articles for article (PubMed ID: 36481907)
1. Prime Editing for the Installation and Correction of Mutations Causing Inherited Retinal Disease: A Brief Methodology.
Tsai YT; da Costa BL; Nolan ND; Caruso SM; Jenny LA; Levi SR; Tsang SH; Quinn PMJ
Methods Mol Biol; 2023; 2560():313-331. PubMed ID: 36481907
[TBL] [Abstract][Full Text] [Related]
2. Prime Editing for Inherited Retinal Diseases.
da Costa BL; Levi SR; Eulau E; Tsai YT; Quinn PMJ
Front Genome Ed; 2021; 3():775330. PubMed ID: 34901928
[TBL] [Abstract][Full Text] [Related]
3. Generation of an Avian Myeloblastosis Virus (AMV) Reverse Transcriptase Prime Editor.
Tsai YT; da Costa BL; Caruso SM; Nolan ND; Levi SR; Tsang SH; Quinn PMJ
Adv Exp Med Biol; 2023; 1415():109-114. PubMed ID: 37440022
[TBL] [Abstract][Full Text] [Related]
4. Gene editing prospects for treating inherited retinal diseases.
Benati D; Patrizi C; Recchia A
J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
[TBL] [Abstract][Full Text] [Related]
5. In vivo application of base and prime editing to treat inherited retinal diseases.
Jo DH; Bae S; Kim HH; Kim JS; Kim JH
Prog Retin Eye Res; 2023 May; 94():101132. PubMed ID: 36241547
[TBL] [Abstract][Full Text] [Related]
6. Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.
Hansen S; McClements ME; Corydon TJ; MacLaren RE
Cells; 2023 Jan; 12(3):. PubMed ID: 36766782
[TBL] [Abstract][Full Text] [Related]
7. Genome-Editing Strategies for Treating Human Retinal Degenerations.
Quinn J; Musa A; Kantor A; McClements ME; Cehajic-Kapetanovic J; MacLaren RE; Xue K
Hum Gene Ther; 2021 Mar; 32(5-6):247-259. PubMed ID: 32993386
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10.
Ruan GX; Barry E; Yu D; Lukason M; Cheng SH; Scaria A
Mol Ther; 2017 Feb; 25(2):331-341. PubMed ID: 28109959
[TBL] [Abstract][Full Text] [Related]
9. Gene Editing Preserves Visual Functions in a Mouse Model of Retinal Degeneration.
Vagni P; Perlini LE; Chenais NAL; Marchetti T; Parrini M; Contestabile A; Cancedda L; Ghezzi D
Front Neurosci; 2019; 13():945. PubMed ID: 31551698
[TBL] [Abstract][Full Text] [Related]
10. Genome Surgery and Gene Therapy in Retinal Disorders.
Chan L; Mahajan VB; Tsang SH
Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
[TBL] [Abstract][Full Text] [Related]
11. Base and Prime Editing in the Retina-From Preclinical Research toward Human Clinical Trials.
Yee T; Wert KJ
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293232
[TBL] [Abstract][Full Text] [Related]
12. Applications of CRISPR/Cas9 in retinal degenerative diseases.
Peng YQ; Tang LS; Yoshida S; Zhou YD
Int J Ophthalmol; 2017; 10(4):646-651. PubMed ID: 28503441
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Therapeutic Evaluation of the Ten Most Prevalent
Lopes da Costa B; Kolesnikova M; Levi SR; Cabral T; Tsang SH; Maumenee IH; Quinn PMJ
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830922
[TBL] [Abstract][Full Text] [Related]
14. Toward the Treatment of Inherited Diseases of the Retina Using CRISPR-Based Gene Editing.
Hernández-Juárez J; Rodríguez-Uribe G; Borooah S
Front Med (Lausanne); 2021; 8():698521. PubMed ID: 34660621
[TBL] [Abstract][Full Text] [Related]
15. CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa.
Wu WH; Tsai YT; Justus S; Lee TT; Zhang L; Lin CS; Bassuk AG; Mahajan VB; Tsang SH
Mol Ther; 2016 Aug; 24(8):1388-94. PubMed ID: 27203441
[TBL] [Abstract][Full Text] [Related]
16. Allele-Specific Knockout by CRISPR/Cas to Treat Autosomal Dominant Retinitis Pigmentosa Caused by the G56R Mutation in NR2E3.
Diakatou M; Dubois G; Erkilic N; Sanjurjo-Soriano C; Meunier I; Kalatzis V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807610
[TBL] [Abstract][Full Text] [Related]
17. Analysis of CRB1 Pathogenic Variants Correctable with CRISPR Base and Prime Editing.
da Costa BL; Jenny LA; Maumenee IH; Tsang SH; Quinn PMJ
Adv Exp Med Biol; 2023; 1415():103-107. PubMed ID: 37440021
[TBL] [Abstract][Full Text] [Related]
18. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
Diakatou M; Manes G; Bocquet B; Meunier I; Kalatzis V
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126147
[No Abstract] [Full Text] [Related]
19. Establishment and visual analysis of CBA/J-Pde6b
Shindo M; Terao M; Takada S; Ichinose M; Matsuzaka E; Yokoi T; Azuma N; Mizuno S; Tsumura H
Exp Anim; 2024 May; 73(2):203-210. PubMed ID: 38171880
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases.
Xue K; MacLaren RE
Expert Opin Investig Drugs; 2020 Oct; 29(10):1163-1170. PubMed ID: 32741234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
